ArticleCancer medicine2021

Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma.

Franziska K Krebs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.